Over the past two years, the O’Neill Institute has been working in partnership with NMAC to examine the status of biomedical HIV prevention research and implementation in the United States. The focus of this work has been to explore how to bring the promise of biomedical HIV prevention to all communities highly impacted by HIV and to ensure that communities of color in particular are not left behind. Biomedical HIV prevention offers a range of tools that can effectively prevent HIV infection. These tools include treatment as prevention (TasP), pre-exposure prophylaxis (PrEP), and post-exposure prophylaxis (PEP).
The report outlines population-specific recommendations to more effectively meet the needs of transgender people of color, Black and Latino gay and bisexual men, women of color, and adolescents and young adults of color. It also includes further steps that can be taken separately in service of transgender women of color and transgender men of color.
Recommendations for Transgender People of Color
Build the capacity of the HIV clinical and non-clinical care systems to meet the needs of trans people of color
Hire trans people of color in our agencies
Generate high quality trans-specific data
Address safety concerns over HIV medications and hormones
Actively counter mistrust of providers and the health system
Cultivate a diverse scientific and clinical workforce trained in applying multidisciplinary approaches
Educate the support systems for Black gay and bisexual men
Recommendations for Latino Gay and Bisexual Men
Bolster community resiliency through culturally responsive and linguistically appropriate interventions
Tailor HIV treatment and prevention efforts to specific Latino subgroups
Promote leadership among Latino gay and bisexual men to address issues disproportionately affecting their peers
Center the voices of undocumented Latinos
Recommendations for Women of Color
Tailor HIV prevention messages to reach women of color
Offer PrEP in family planning clinics
Educate providers about the importance of PrEP for women of color
Support the adoption of new models of trauma-informed primary care
Address unique issues related to juggling family, work, and other responsibilities
Recommendations for Adolescents and Young Adults of Color
Work to obtain FDA approval of PrEP for adolescents under age 18
Identify and share best practices for addressing consent, confidentiality, and cost barriers for PrEP
Work to augment resources dedicated to reach young people of color who need ART or PrEP and support them in staying in care and adhering to their medication
Disseminate HIV prevention information through youth serving organizations
Build support for comprehensive health education and the integration of PrEP information into health education curricula
Educate communities of color about state laws that affect the sexual health of young people
Increasing access to biomedical HIV prevention without reaching people and communities of color and understanding their needs, values, cultural backgrounds, and barriers to care will cause us to expand rather than shrink HIV-related disparities and health inequities. To learn more, you can read this report and the “Blueprint for HIV Biomedical Prevention: State of the State” report here.
The views reflected in this expert column are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.